# A Phase I Study to Assess Novel Cream in a Psoriasis Plaque Test

> **NCT00763204** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 12 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** AN2728 Cream, 2%
- **DRUG:** AN2728 Cream, 1%
- **DRUG:** AN2728 Cream, 0.3%
- **DRUG:** AN2728 Cream Vehicle
- **DRUG:** Betnesol®-V Creme, 0.1%

## Key facts

- **NCT ID:** NCT00763204
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02-29
- **Primary completion:** 2008-03-07
- **Final completion:** 2008-03-07
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2019-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00763204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00763204, "A Phase I Study to Assess Novel Cream in a Psoriasis Plaque Test". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00763204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*